172 related articles for article (PubMed ID: 38004425)
1. Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery.
Mori M; Villa S; Chiarelli LR; Meneghetti F; Bellinzoni M
Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004425
[TBL] [Abstract][Full Text] [Related]
2. The structure of MbtI from Mycobacterium tuberculosis, the first enzyme in the biosynthesis of the siderophore mycobactin, reveals it to be a salicylate synthase.
Harrison AJ; Yu M; Gårdenborg T; Middleditch M; Ramsay RJ; Baker EN; Lott JS
J Bacteriol; 2006 Sep; 188(17):6081-91. PubMed ID: 16923875
[TBL] [Abstract][Full Text] [Related]
3. Implications of binding mode and active site flexibility for inhibitor potency against the salicylate synthase from Mycobacterium tuberculosis.
Chi G; Manos-Turvey A; O'Connor PD; Johnston JM; Evans GL; Baker EN; Payne RJ; Lott JS; Bulloch EM
Biochemistry; 2012 Jun; 51(24):4868-79. PubMed ID: 22607697
[TBL] [Abstract][Full Text] [Related]
4. Shedding X-ray Light on the Role of Magnesium in the Activity of
Mori M; Stelitano G; Gelain A; Pini E; Chiarelli LR; Sammartino JC; Poli G; Tuccinardi T; Beretta G; Porta A; Bellinzoni M; Villa S; Meneghetti F
J Med Chem; 2020 Jul; 63(13):7066-7080. PubMed ID: 32530281
[TBL] [Abstract][Full Text] [Related]
5. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
[TBL] [Abstract][Full Text] [Related]
6. Structure and mechanism of MbtI, the salicylate synthase from Mycobacterium tuberculosis.
Zwahlen J; Kolappan S; Zhou R; Kisker C; Tonge PJ
Biochemistry; 2007 Jan; 46(4):954-64. PubMed ID: 17240979
[TBL] [Abstract][Full Text] [Related]
7. Targeting Siderophore-Mediated Iron Uptake in
Mori M; Stelitano G; Cazzaniga G; Gelain A; Tresoldi A; Cocorullo M; Roversi M; Chiarelli LR; Tomaiuolo M; Delre P; Mangiatordi GF; Griego A; Rizzello L; Cassetta A; Covaceuszach S; Villa S; Meneghetti F
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839823
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections.
Mori M; Stelitano G; Griego A; Chiarelli LR; Cazzaniga G; Gelain A; Pini E; Camera M; Canzano P; Fumagalli A; Scarpa E; Cordiglieri C; Rizzello L; Villa S; Meneghetti F
Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015139
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents.
Mori M; Stelitano G; Chiarelli LR; Cazzaniga G; Gelain A; Barlocco D; Pini E; Meneghetti F; Villa S
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33668554
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of M. tuberculosis salicylate synthase (MbtI) inhibitors designed to probe plasticity in the active site.
Manos-Turvey A; Cergol KM; Salam NK; Bulloch EM; Chi G; Pang A; Britton WJ; West NP; Baker EN; Lott JS; Payne RJ
Org Biomol Chem; 2012 Dec; 10(46):9223-36. PubMed ID: 23108268
[TBL] [Abstract][Full Text] [Related]
11. Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents.
Chiarelli LR; Mori M; Barlocco D; Beretta G; Gelain A; Pini E; Porcino M; Mori G; Stelitano G; Costantino L; Lapillo M; Bonanni D; Poli G; Tuccinardi T; Villa S; Meneghetti F
Eur J Med Chem; 2018 Jul; 155():754-763. PubMed ID: 29940465
[TBL] [Abstract][Full Text] [Related]
12. Integration of ligand and structure based approaches for identification of novel MbtI inhibitors in Mycobacterium tuberculosis and molecular dynamics simulation studies.
Maganti L; Grandhi P; Ghoshal N
J Mol Graph Model; 2016 Nov; 70():14-22. PubMed ID: 27639087
[TBL] [Abstract][Full Text] [Related]
13. New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents.
Chiarelli LR; Mori M; Beretta G; Gelain A; Pini E; Sammartino JC; Stelitano G; Barlocco D; Costantino L; Lapillo M; Poli G; Caligiuri I; Rizzolio F; Bellinzoni M; Tuccinardi T; Villa S; Meneghetti F
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):823-828. PubMed ID: 30889995
[TBL] [Abstract][Full Text] [Related]
14. New Chromane-Based Derivatives as Inhibitors of
Pini E; Poli G; Tuccinardi T; Chiarelli LR; Mori M; Gelain A; Costantino L; Villa S; Meneghetti F; Barlocco D
Molecules; 2018 Jun; 23(7):. PubMed ID: 29933627
[TBL] [Abstract][Full Text] [Related]
15. Stereocontrolled Synthesis of a Potential Transition-State Inhibitor of the Salicylate Synthase MbtI from Mycobacterium tuberculosis.
Liu Z; Liu F; Aldrich CC
J Org Chem; 2015 Jul; 80(13):6545-52. PubMed ID: 26035083
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Transition-State Inhibitors of Chorismate Utilizing Enzymes from Bromobenzene cis-1,2-Dihydrodiol.
Zhang XK; Liu F; Fiers WD; Sun WM; Guo J; Liu Z; Aldrich CC
J Org Chem; 2017 Apr; 82(7):3432-3440. PubMed ID: 28282140
[TBL] [Abstract][Full Text] [Related]
17. Understanding the different activities of highly promiscuous MbtI by computational methods.
Ferrer S; Martí S; Moliner V; Tuñón I; Bertrán J
Phys Chem Chem Phys; 2012 Mar; 14(10):3482-9. PubMed ID: 22307014
[TBL] [Abstract][Full Text] [Related]
18. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the salicylate synthase (MbtI) from Mycobacterium tuberculosis discovered by high-throughput screening.
Vasan M; Neres J; Williams J; Wilson DJ; Teitelbaum AM; Remmel RP; Aldrich CC
ChemMedChem; 2010 Dec; 5(12):2079-87. PubMed ID: 21053346
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of Yersinia enterocolitica salicylate synthase and its complex with the reaction products salicylate and pyruvate.
Kerbarh O; Chirgadze DY; Blundell TL; Abell C
J Mol Biol; 2006 Mar; 357(2):524-34. PubMed ID: 16434053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
